ALB and hepatocellular carcinoma: Studies conducted by Kao et al. [72], An et al. [73], Chen et al. [74], and Long et al. [75] showed that a high pre-treatment serum ALB–BIL grade was a factor that was independently associated with worse OS and RFS in HCC patients treated with RFA or PMWA.